Source link : https://newshealth.biz/health-news/smc-rejects-sotatercept-for-pulmonary-hypertension/
Scotland’s medicines regulator has rejected sotatercept for PAH, citing insufficient cost-effectiveness evidence despite improved exercise capacity. Medscape News UK Source link : https://www.medscape.com/viewarticle/smc-rejects-sotatercept-pulmonary-hypertension-2026a100042g?src=rss Author : Publish date : 2026-02-09 17:08:00 Copyright for syndicated content belongs to the linked Source.
The post SMC Rejects Sotatercept For Pulmonary Hypertension first appeared on News Health.
—-
Author : News Health
Publish date : 2026-02-09 17:08:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8